Alexander Fleming, MD
Kinexum, Harpers Ferry, West Virginia
Dr. Alexander Fleming is Founder and Executive Chairman of Kinexum, a company of professionals from across the world with diverse expertise in developing drugs, biotech products, medical devices, and digital health technologies. Dr. Fleming received his M.D. and internal medicine training from Emory, fellowship training in endocrinology at Vanderbilt and metabolism at National Institutes of Health, where he was a senior fellow.
At the US Food and Drug Administration from 1986-98, led many landmark drug and biotech approvals and innovations as well as represented the Agency at the International Conference on Harmonization (ICH) and World Health Organization.
Dr. Fleming serves on the joint technology working groups of the European Association for the Study of Diabetes and American Diabetes Association.
Dr. Fleming coined the term, Metabesity and organized the first Congress on Metabesity in London in October 2017. He founded the Kitalys Institute to advance all measures that can improve healthspan.